Aptose Biosciences (TSE:APS) Issues Earnings Results

Aptose Biosciences (TSE:APS) (NASDAQ:APTO) posted its quarterly earnings data on Thursday. The biotechnology company reported C($2.01) earnings per share for the quarter, FiscalAI reports.

Aptose Biosciences Price Performance

APS stock traded down C$0.02 during trading on Friday, reaching C$1.94. 154 shares of the company were exchanged, compared to its average volume of 4,702. The company has a market capitalization of C$4.95 million, a price-to-earnings ratio of -0.25 and a beta of -0.05. The company has a debt-to-equity ratio of -117.37, a current ratio of 1.05 and a quick ratio of 5.41. The company has a 50-day moving average of C$1.73 and a two-hundred day moving average of C$1.92. Aptose Biosciences has a twelve month low of C$1.02 and a twelve month high of C$16.50.

About Aptose Biosciences

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.